Consider your dosing needs when choosing concentration
As widely applied chemoradiotherapy is showing its drawbacks, such as frequent resistance and toxic side effects, cell death induction is becoming increasingly popular for developing novel cancer treatment
Dihexa Based on 6 publication(s) in Google Scholar Dihexa, an oligopeptide drug, is an orally active and blood-brain barrier-permeable angiotensin IV analog
Medical Care All treatments are provided by trained healthcare staff in our Bedford IV infusion clinic
Without adequate glutathione stores, Phase 1 toxic intermediates accumulate in the liver and bloodstream, causing severe systemic inflammation and triggering hypersensitivity reactions commonly seen in patients with complex chronic illnesses
Antioxid Redox Signal 9 , 4989 (2007)